-
Product Insights
![]()
Red Hook JV – 145 Wolcott Street Mixed-Use Development – New York
Equip yourself with the essential tools needed to make informed and profitable decisions with our Red Hook JV - 145 Wolcott Street Mixed-Use Development - New York report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
![]()
EcoDev/ JV Parc – Duntrune Battery Energy Storage Plant 80 MW – Angus
Equip yourself with the essential tools needed to make informed and profitable decisions with our EcoDev/ JV Parc - Duntrune Battery Energy Storage Plant 80 MW - Angus report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BMX-001 in Rectal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BMX-001 in Rectal Cancer Drug Details: BMX-001 is under development for the treatment of allergic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BMX-001 in Laryngeal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BMX-001 in Laryngeal Cancer Drug Details: BMX-001 is under development for the treatment of allergic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BMX-001 in Hypopharyngeal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BMX-001 in Hypopharyngeal Cancer Drug Details: BMX-001 is under development for the treatment of allergic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BMX-001 in Oropharyngeal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BMX-001 in Oropharyngeal Cancer Drug Details: BMX-001 is under development for the treatment of allergic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BMX-001 in Oral Cavity (Mouth) Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BMX-001 in Oral Cavity (Mouth) Cancer Drug Details: BMX-001 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BMX-001 in Head And Neck Cancer Squamous Cell Carcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BMX-001 in Head And Neck Cancer Squamous Cell Carcinoma Drug Details: BMX-001 is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BMX-001 in High-Grade Glioma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.BMX-001 in High-Grade GliomaDrug Details: BMX-001 is under development for the treatment of allergic dermatitis, anal...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Rivaroxaban in Stroke
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rivaroxaban in Stroke Drug Details: Rivaroxaban is under development for the treatment of stroke and...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MET-2 in Clostridioides difficile Infections (Clostridium difficile Associated Disease)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.MET-2 in Clostridioides difficile Infections (Clostridium difficile Associated Disease) Drug Details:MET-2 is under development for the...
-
Product Insights
![]()
Houbolt Road Ext JV/ Joliet City – Will County to I-80 Toll Bridge – Illinois
Equip yourself with the essential tools needed to make informed and profitable decisions with our Houbolt Road Ext JV/ Joliet City - Will County to I-80 Toll Bridge - Illinois report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SGR-1505 in B-Cell Non-Hodgkin Lymphoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.SGR-1505 in B-Cell Non-Hodgkin LymphomaDrug Details:SDGR-3 is under development for the treatment of BTK-resistant or relapsed...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MIL-62 in Follicular Lymphoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. MIL-62 in Follicular Lymphoma Drug Details: MIL-62 is under development for the treatment of chronic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Cabometyx in Oropharyngeal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Cabometyx in Oropharyngeal Cancer Drug Details: Cabozantinib s-malate (Cabometyx, Aptimetyx) is a s-malate salt form...
-
Sector Analysis
![]()
Methanol Capacity and Capital Expenditure Forecast by Region, Countries, Companies and Projects, 2023-2030
Methanol Capacity and Capital Expenditure Market Overview The Methanol capacity was 171.84mtpa in 2022. Around 123 planned and announced plants are slated to be online by 2030, primarily in the Former Soviet Union and the Middle East. FSU has 30 planned and announced plants, of which Russia has 22. In Middle East, the majority of capacity additions are in Iran. Methanol Capacity Market Outlook, 2022-2030 (mtpa) For more insights into the Methanol capacity and capex market forecast, download a free...
-
Company Profile
![]()
Avenira Ltd – Company Profile
Avenira Ltd (Avenira) formerly Minemakers Ltd, is a mining and mineral exploration and development company that acquires, explores, produces and develops tin, tungsten, phosphate, fluorite, iron, uranium, and minerals deposit properties. The company operates its exploration properties in Wonarah that evaluates ore feed for downstream processing to fertilizers, and Baobab Phosphate Project in the Republic of Senegal. It also holds interest in JV Company, Union Resources Ltd, Namibian Marine Phosphat e (Pty) Ltd, and Tungeni Investments cc. Avenira's projects include...
Add to Basket -
Company Profile
![]()
Rox Resources Limited – Company Profile
Rox Resources Limited (Rox) is a gold exploration and development company. Its major projects include Mt Fisher Gold project and Youanmi Gold Project. It had 70% of ownership and operator of the historic Youanmi Gold Project near Mt Magnet, which is 480 km northeast of Perth and owns 100% of Mt Fisher Gold Project, which is 140 kilometres southeast of Wiluna. The company’s Youanmi Gold Project consist of four unincorporated joint ventures such as OYG JV, VMC JV, Youanmi JV...
Add to Basket -
Company Profile
![]()
Arafura Rare Earths Ltd – Company Profile
Arafura Rare Earths Ltd (Arafura) is a rare earth metals mining and exploration company. It is involved in exploration and development of various mineral sources including rare earths, phosphate, uranium, iron, vanadium, and gold. The company had major project such as Nolan project. It also owns other exploration projects including Aileron-Reynolds project and Bonya JV. The company’s rare earth products are used in magnetic, optical, catalytic, and electronic applications in key growth sectors such as automotive, clean energy, and consumer...
Add to Basket -
Company Profile
![]()
Prodigy Gold NL – Company Profile
Prodigy Gold NL (Prodigy Gold), formerly ABM Resources NL, is a mining company. It is involved in exploration of gold, zinc, lead and copper. The company’s projects include the Buccaneer project, Hyperion project, Old Pirate project, Tobruk and Monza JV project, Lake Mackay Project, and North Arunta Project. The company operates Lake Mackay Project in a joint venture agreement with Independence Group (IGO) and operates North Arunta Project in a joint venture agreement with Gladiator Resources. It carries out the...
Add to Basket
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.